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INTRODUCTION 
 A biological approach to understanding people diagnosed with ‘schizophrenia’ has, for decades, 
dominated not only clinical services but also the way people with this diagnosis are viewed by medical 
professionals (Deacon, 2013; Larkings & Brown, 2018; Lebowitz & Ahn, 2014; Read, Haslam & Magliano, 
2013a) and portrayed by the media (Magliano & Marassi, 2018; Robinson, Turk, Jilka & Cella, 2019). 
Nevertheless, surveys in more than 20 countries, including Italy (Read, Magliano & Beavan, 2013b; Magliano, 
Fiorillo, De Rosa, Malangone, & Maj, 2004), find that the public (including people with a diagnosis of 
‘schizophrenia’ and their families) endorse psycho-social causes far more than bio-genetic ones (Read, 
Haslam, Sayce, & Davies, 2006; Schomerus et al., 2012). Read et al. (2013b) reviewed studies on beliefs 
about the causes of schizophrenia in 84 samples of people from 25 countries. Findings from this review 
revealed that 61 out of the 84 examined samples (73%) believed more strongly in psychosocial than biogenetic 
causes, 6 samples (7%) gave equal emphasis and 17 (20%) favoured biogenetic causes. For instance, the 
most frequently cited causes of schizophrenia was “problems in interpersonal relationships” (65%) in Japan, 
“psychosocial stress” (83%) in South Africa, “problems from childhood such as being badly treated or abused, 
losing parents when young, or coming from a broking home” (91%) in Australia, and “stress” (72%) in Italy. 
After entering mental health services, however, the biomedical perspective of many professionals may 
influence the way people view their own difficulties (Ahn, Proctor & Flanagan, 2009; Carter, Read, Pyle, & 
Morrison, 2017; Magliano et al., 2009; Rusch, Todd, Bodenhausen, & Corrigan, 2010), as well as the 
treatments they prefer and their perceived chances of recovery (Larkings & Brown, 2018). Presenting 
schizophrenia as "a disease like any other", i.e., equating the experience of psychosis with that of having a 
physical disease, was intended to improve social acceptance of "schizophrenics” by reducing blame for this 
condition. In fact, explaining schizophrenia as caused by genetic factors, chemical imbalances and brain 
anomalies causes prognostic pessimism, perceptions of dangerousness and unpredictability, and desire for 
social distance from these people (Angermeyer & Matschinger, 2005; Haslam, 2011; Kvaale, Haslam, & 
Gottdiener, 2013; Read et al., 2013a). 
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In contrast with the large number of studies that have documented the influence of causal beliefs on public 
attitudes toward people diagnosed with schizophrenia (Gausgruber, Meise, Katsching, Schöny, & 
Fleischhacker, 2007; Jorm & Griffiths, 2008; Pattin, Verhaeghe, Sercu, & Bracke, 2013; Phelan., 2005; 
Schomerus, Matschinger, & Angermeyer, 2014; Wiesjhan, Jung, Kremser, Rief, & Lincoln, 2016), relatively 
few studies have specifically investigated the potential impact of doctors’ causal explanations on clinical 
practice (Ahn et al., 2009; Corrigan et al., 2014; Lebowitz & Ahn, 2014).  
Available data suggest that health professionals might be significantly influenced in their therapeutic 
choices and clinical approach to people experiencing psychosis by the etiological model they adhere to. 
Lebowitz & Ahn, (2014) found that psychiatrists showed less empathy towards people diagnosed with 
schizophrenia (and other diagnoses) and placed less emphasis on psychotherapy when they explained 
symptoms in terms of biological rather than psychosocial factors. Similarly, Ahn et al (2009) found that mental 
health staff who adhere to a biogenetic model attributed greater usefulness to drugs, while staff who believed 
more in psychosocial placed greater value on psychotherapies. Carter et al., (2017) reported that mental health 
clinicians with psychosocial beliefs of psychosis were more likely to rate CBT as effective, whereas those with 
biological models were more likely to endorse medication. 
The impact of causal explanations on non-psychiatric medical staff, however, remains largely unexplored. 
Because of the high prevalence of physical health problems in people diagnosed with schizophrenia 
(Vancampfort et al., 2015) and the suboptimal medical care they often receive (Shefer, Henderson, Howard, 
Murray, & Thornicroft, 2014; Thornicroft, Rose & Kassam, 2007), research in non-psychiatric health contexts 
is needed. Recently, two related studies on views about schizophrenia among non-psychiatric medical doctors 
have been carried out in Italy. The first study, carried out in 2014, examined the influence of the diagnostic 
label “schizophrenia” on the causal beliefs of 387 GPs after reading a clinical, ICD-10 description of a person 
with this disorder (Magliano et al., 2017). Those who used the diagnostic label ‘schizophrenia’ (either actively 
assigning it themselves to an undiagnosed version of the vignette or being given the diagnosis in the vignette) 
were more likely to endorse biogenetic causal explanations, were more pessimistic about recovery, and 
expressed more restrictive beliefs about how people with this disorder should be treated in non-psychiatric 
hospital wards. The diagnostic label ‘schizophrenia’ was also related to a perception of dangerousness and 
the belief that other people desired social distance. The second study, carried out in 2017, was a partial 
extension of the GPs study. This study investigated views of schizophrenia and depression among non-
psychiatric medical specialists working in community centres of the same geographical area of the GPs in the 
first study (BLINDED). The 211 participants were randomly assigned to read either the same clinical 
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description of schizophrenia adopted in the GPs study or a clinical description of depression. The study found 
that specialists had a more discriminatory approach toward people with schizophrenia than toward those with 
depression. Moreover, medical specialists were more skeptical regarding the capacities of people with 
schizophrenia to care for their own health, and perceived people with this disorder as kept at greater distance 
by others.  
The current article examines the impact of causal explanations of schizophrenia on views about 
treatments and prognosis among combined subsets of participants from each of the two studies.  Specifically, 
the sample of the current study includes the 192 GPs and the 114 non-psychiatric medical specialists who 
completed the revised ‘Opinions on mental disorders Questionnaire’ (OQ; Magliano et al., 2017) after reading 
the same, undiagnosed clinical description of schizophrenia.  
In particular, this study aimed to investigate whether the causes indicated by this combination of two sets 
of non-psychiatric doctors as the most important in the development of schizophrenia would be related to their 
views about treatments and prognosis. In particular, we tested the following six hypotheses.  
Doctors who believe that the most important cause of schizophrenia is a bio-genetic factor would, 
compared to those who believed that a psychosocial factor is the most important cause: 
1.  more strongly endorse medication 
2. less strongly endorse psychological therapies 
3. be surer of the need for life-long pharmacological treatments 
4. more frequently recommend a psychiatrist 
5. less frequently recommend a psychologist  
6. be more pessimistic about the probability of recovery. 
 
METHODS 
Study design and procedure 
The study was approved by the Research Ethical Board of the Department of Psychology (University 
of …, Italy) and authorized by the …. Local Health Authority. The survey was carried out among GPs and 
registered non-psychiatric medical specialists (medical, surgical and diagnostic/laboratory clinicians) working 
in the outpatient community centers of the Primary Care Units of the …. Central Health Authority. This 
metropolitan area (population approximately 1 million) was chosen pragmatically because of its proximity to 
the Department of Psychology in order to facilitate the face-to-face data collection. Data was collected from 
June 2013 to March 2014 (GPs study), and from January to December 2017 (non-psychiatric medical 
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specialists study). No relevant change in the organization of the health care services or in the availability of 
health professional resources occurred in this time frame at local or regional level. 
In both the studies, potential participants were contacted personally by a researcher and invited to join a 
study on their views about mental disorders. In the GPs study, 50% of participants completed the OQ after 
reading a clinical description of schizophrenia (Appendix A) and were included in the current study’s sample. 
The remaining 50% of participating GPs were excluded because they completed the questionnaire in relation 
to the diagnostic label ‘schizophrenia’ given in the questionnaire (i.e., no clinical description of the disorder 
was provided). Details of the study design are reported in Magliano et al., 2017. In the medical specialists’ 
study (BLINDED), 50% of participants completed the OQ after reading a clinical description of schizophrenia 
(Appendix A) and were included in this study sample. The remaining 50% of participating doctors were 
excluded because they completed the OQ after reading a clinical, undiagnosed description of depression. In 
both the studies, the questionnaire was self-administered either in the presence of the researcher at the 
physician’s office or by themselves, according to their preference. Information on participants’ demographic 
variables and professional background was collected.  
 
Sample characteristics 
 Of the 430 GPs approached (50% of GPs working in the selected catchment area), 387 gave 
informed consent to participate (90%). Of these 387, 192 completed the questionnaire after reading the clinical 
description of schizophrenia and were included in this study. Of the 255 medical specialists approached (90% 
of all medical specialists working in the community in that catchment area), 211 (82.7%) agreed to participate. 
Of these 211, 114 completed the questionnaire after reading the description of schizophrenia and were 
included in this study. One questionnaire was subsequently excluded due to missing data. Therefore, the final 
sample for this study was 305 doctors (192 GPs and 113 medical specialists). Participants’ socio-demographic 
and professional background characteristics are reported in Table 1. The 305 participants were mainly male 
(77%), with a mean age of 57.8 years. Nearly all participants had achieved their MD degree more than 20 
years previously and most reported having treated at least one client diagnosed with ‘schizophrenia’. GPs and 
medical specialists were comparable in socio-demographic variables and professional background 
characteristics, except gender (male: GPs 82.3% vs. medical specialists 68.1%; χ2=8.05, df 1, p<0.005).  
 
Assessment instrument 
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The revised version of the OQ (Magliano et al., 2017) is a  self-report tool including: a) 16 yes/no items 
on beliefs of  bio-psycho-social factors involved in the development of the disorder in question; b) two open 
questions about what is the ‘most important’ and the ‘most frequent’ cause of the clinical description; c) 4 
yes/no items on beliefs about which professionals should be involved in the treatment of People With a given 
Disorder (PWD); d) 23 items, grouped into 10 subscales, addressing beliefs about: 1-3) usefulness of drugs  
and  psychological therapies and need of life-term pharmacological treatments; 4) probability of recovery; 5) 
insight of PWD about their own mental health problems; 6) capacity of PWD to report their health conditions 
to medical doctors; 7) perception of others’ need for social distance from PWD; 8) dangerousness; 9) 
discriminatory approach to  PWD in non-psychiatric hospital wards; 10) difficulties of PWD in having romantic 
relationships. Section d items are rated on a 3-point scales (1= “not true”, 2 = “partially true”, 3 = “completely 
true”). The psychometric properties of OQ’s section d were previously tested on  a sample of  387 GPs and 
found to be satisfactory (Confirmatory Factor Analysis: model χ2 =320.35, df 188, N = 387, p <0.05; non normed 
fit index [NNFI] = 0.95; comparative fit index [CFI] = 0.97; root mean square error of approximation  [RMSEA] 
= 0.04 (0.03; 0.05); standardized root mean square residual [SRMR] = 0.04; all factor loadings significant for 
p < .001; Cronbach’s α values of the factors ranging from 0.65 to 0.83). The revised OQ was developed in 
Italian and only the Italian version has been validated. The questionnaire is available from the corresponding 
author upon request. An English translation of all items’ contents is reported in Magliano et al., 2017.  
In this study sample, Cronbach’s α values of OQ section d subscales ranged from 0.66 to 0.84. For the 
purpose of this article, only items from the OQ sections a to c, and from the subscale 1 to 4 of section d were 
analyzed.  
 
Statistical analysis 
The OQ section a) items were dichotomised as biogenetic causes (heredity, chemical imbalance, illness 
during the pregnancy, physical illness, use of alcohol and street drugs) and psychosocial causes (stress, work 
difficulties, family conflicts, poor childhood/abandonment, traumatic events, sexual abuse, physical violence, 
psychological violence, disillusionment in love, bereavement).  Respondents’ causal models were defined as 
biogenetic, if he/she had listed only biogenetic causal explanations; as psychosocial, if he/she had only listed 
psychosocial causal explanations; and, as biopsychosocial, if the respondent had listed both biogenetic and 
psychosocial causes. Responses to the section b open item, “in your opinion, what is the most important cause 
of this disorder?”, were dichotomized as biogenetic and psychosocial by applying the above-mentioned 
classification. Chi square (χ2.) with Cramer’s V was used to investigate the association of the type of most 
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important cause (biogenetic vs. psychosocial) with the recommendations of types of professionals 
(psychiatrists, psychologists, neurologists, GPs). Multivariate Analysis of Variance (MANOVA) was performed 
to explore the association of most important cause (biogenetic vs. psychosocial - independent variable) on 
respondents’ beliefs about usefulness of drugs and psychological therapies, need of long term 
pharmacological treatments and probability of recovery (mean scores of OQ section d 1-4 subscales, 
dependent variables). Statistical significance level was set at p<0.05. Statistical analyses were performed 
using SPSS, version 21 (IBM, 2012). 
 
RESULTS 
The factors most frequently reported as involved in the development of schizophrenia were heredity 
(65.2%) and use of street drugs (54.1%), followed by psychological violence (45.9%) and traumatic events 
(44.6%; Table 2). The majority of physicians (75.1%) endorsed at least one biological and one psychosocial 
cause, 16.4% reported only biological factors, and 8.5% endorsed only psychosocial causes. 
Of the 305 participating doctors, 264 (86.5%) expressed their opinion about the most important cause of 
schizophrenia (see Table 3) while 41 (13.4%) either did not reply (29) or stated that the most important cause 
was a combination of biological and psychosocial causes (12). Of the 264 valid responses, 53.8% indicated a 
biogenetic cause (most frequently heredity - 60.6%) and 46.2% a psychosocial cause (most frequently stress 
- 18.8%). (When considering these overall percentages for the two general types of causes it must be noted 
that there were 10 psychosocial causes offered and only six biogenetic ones). 
Eighty-seven percent of doctors recommended a psychiatrist, 47.9% recommended a psychologist, 
23.8% a GP and 18.5% a neurologist. Both a psychiatrist and a psychologist were recommended by 42.2%. 
Fifty-two percent believed that it was completely true that “drugs are useful for the disorder”. Moreover, 33.9% 
believed that it was completely true that “PWD must take drugs all their life”, and 15% thought that is was 
completely true that “if stop taking drugs, PWD become dangerous”. Fifty-six percent of physicians thought it 
completely true that “psychological interventions are useful for the disorder” Only 29.1% believed it was 
completely true that “people with this disorder can recover” (see Table 4).  
Participants stating that the most important cause was biogenetic more frequently recommended a 
psychiatrist (96.5% vs. 77.9%; χ2= 21.4, df 1, p<0.0001, Cramer’s V=.28, p<0.0001) and less frequently a 
psychologist (42.2% vs. 56.6%; χ2=5.37, df 1, p<0.02, Cramer’s V=.14, p<0.02). Multivariate analyses of 
variance revealed a significant effect of biogenetic vs. psychosocial most important causes on three subscales 
(see Table 5). In particular, compared to doctors who indicated a psychosocial cause, those who indicated a 
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biogenetic cause were more pessimistic about recovery (biogenetic mean ± SD: 2.09 ± 0.56 vs. psychosocial 
2.35 ± 0.55, F (1, 265)=13.96, p<0.0001), more confident about the usefulness of drugs (2.62 ± 0.51 vs.2.38 
± 0.54, F (1, 265): 13.04, p<0.0001) and more convinced of the need of life-long pharmacological  treatment 
(2.11 ± 0.53 vs. 1.89 ± 0.55, F (1, 265)= 12.04, p<0.001; Wilks’λ = 0.89, F (4,259) = 7.80, p< 0.0001). 
 
DISCUSSION 
Interpretation of the results 
The findings of this study highlight that most non-psychiatric doctors view schizophrenia as a disorder 
caused by a combination of biogenetic and psychosocial factors, but that most place more emphasis on 
biological factors, particularly genetics (65.2%). As hypothesized, and perhaps unsurprisingly, the results of 
this study confirm previous findings that viewing schizophrenia as mainly due to a biological cause is 
associated with greater confidence in drugs, higher conviction of the need of life-long pharmacological 
treatments, and prognostic pessimism (Ahn et al., 2009; Carter et al., 2017; Kvaale et al., 2013; Larkings and 
Brown, 2018). Moreover, adherence to a biologically-oriented model of schizophrenia may led to an 
underestimation of the value of psychologists (Deacon, 2013; Magliano, Read,  Sagliocchi, Patalano, & 
Oliviero, 2013).  Strong belief in the efficacy and safety of antipsychotic medication has been brought into 
question by recent studies and reviews (Bola, Lehtinen, Cullberg, & Ciompi, 2009; Bola, Kalo & Soydan, 2011; 
Hutton, Weinmann, Bola, & Read, 2013; Jung et al., 2016; Read & Williams, 2019). 
In total, 75.1% of respondents endorsed at least one biological and one psychological cause in 
schizophrenia, mostly psychological violence and traumatic events. This is a positive finding suggesting that 
most non-psychiatric doctors have a balanced biopsychosocial interpretation of this disorder. However, the 
fact that 53.8% affirmed that the most important cause is biological - mainly heredity - suggests that many 
respondents may consider psychosocial causes as mere trigger factors rather than “true” causal factors of 
psychosis (Magliano et al., 2013; Read, Bental & Fosse, 2009). Numerous reviews and critiques have 
demonstrated that the role of genetics in the development of psychosis has been greatly exaggerated and the 
methodological failings of many of the studies and concepts underestimated (Joseph, 2006; Joseph, 2013). 
The relatively lower importance given to psychosocial factors by most non-psychiatric doctors may in part 
explain why only 47.9% of respondents recommended a psychologist and the fact that 42.8% were somewhat 
or very doubtful about the usefulness of psychological therapies (see Table 4). The relatively low percentage 
of respondents recommending a psychologist may be partly explained by the low availability of psychological 
interventions for people with severe mental disorders in routine settings (Huddock et al., 2014; Magliano et al., 
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2002; Prytys, Garety, Jolley, Onwumere, & Craig, 2011), and partly by the low exposure to evidence-based 
biopsychosocial approaches in the curricula of university medical training courses and continuous medical 
education programmes (Sartorius et al., 2010). There is good evidence that psychological therapies, including 
but not limited to Cognitive-Behavioural Therapy, are at least as effective than medication, and far safer 
(Morrison, 2013; Morrison et al., 2014). 
 Seventy-five of the sample, believed – partially or completely – that people with the disorder must take 
psychotropic drugs for the rest of their lives and that 63.9% believed – partially or completely –  that these 
people become dangerous if they stop drugs. These results are in line with previous findings on the association 
of biogenetic explanations and pharmacological treatments with a focus on behavioural control and 
containment (Ahn et al., 2009; Carter et al., 2017). These findings that may have implications for physical 
health care of service users directly, or on the multidisciplinary approaches to physical health in schizophrenia 
more generally. In particular, these results may have an impact on non-psychiatric medical doctors’ clinical 
decisions regarding people diagnosed with schizophrenia (with 82.2% of participants reporting that they have 
treated such people). For instance, if doctors believed that people with the disorder need to take psychotropic 
drugs all their life to control the symptoms of this disorder, they might not recommend drug withdrawal in case 
of severe side effects. Moreover, doctors’ beliefs about treatments may influence recommendations these 
physicians may suggest to their clients regarding treatments and professionals to be involved in the care. 
A percentage of 29.1% of respondents completely believe that people diagnosed with schizophrenia can 
recover, although 61.1% partially believe this. Since no specific definition of “recovery” was provided in the 
questionnaire, it is likely that respondents interpreted “recovery” in different ways (Ng, Pearson, Chen &  Law, 
2011).  Some respondents may have interpreted recovery as implying being symptom-free and without need 
of further treatments, as occurs in some acute physical diseases. Others may have viewed recovery as living 
a meaningful life with some symptoms and with occasional need for professional support (Bellack, 2006). 
However it is interpreted, prognostic pessimism may negatively influence clinical decisions (Adewuya & 
Oguntade, 2007; Corrigan et al., 2014; Vistorte et al., 2018), the information clinicians provide to their clients 
(Gumus, 2008), and, perhaps most importantly, clients’ own beliefs about their chances of recovery (Carter et 
al., 2017; Larkings & Brown, 2018).Our findings suggest the need to provide some non-psychiatric doctors 
with training on the multiple and varied interacting causes of the symptoms that elicit a diagnosis of 
‘schizophrenia’, including the psycho-social factors (Read & Dillon, 2013), and on the efficacy and safety of 
the broad range of available evidence-based treatments (Bentall, 2013; Morrison, 2013; Read & Dillon, 2013). 
Educational initiatives for non-psychiatric doctors should also include information on actual rates of recovery 
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(Tibaldi & Govers, 2011; Varese et al., 2012; Warner, 2009) and the actual risks of dangerous behaviours in 
schizophrenia. These findings also indicate the need to sensitize non-psychiatric doctors on the effects of 
stigma (defined by Goffman as “an attribute that links a person to an undesirable stereotype, leading other 
people to reduce the bearer from a whole and usual person to a tainted, discounted one”, reported in Stuber, 
Meyer & Link, 2008)  and its toxic effects on health practices (Sartorius et al., 2010), especially the view of the 
“schizophrenic” as a dangerous person affected by an incurable illness requiring life-long pharmacological 
treatments (Read et al., 2009).  
Education and contact with people diagnosed with schizophrenia are both stated to have some impact in 
reducing public stigma and prejudice against people with serious mental health problems (Corrigan et al., 
2012) and in health contexts (Henderson et al., 2014; Ucok et al., 2011). In Italy, educational initiatives for 
future health, based on participation of people with experience of the psychiatric system and who have been 
given a schizophrenia diagnosis (Magliano et al., 2014; Magliano et al., 2016), resulted in increased 
endorsement of psychosocial causes, more frequent recommendation of psychologists, greater prognostic 
optimism and increased conviction of the usefulness of both pharmacological and psychological treatments. 
We are currently seeking to initiate similar educational initiatives for non-mental health professionals. At the 
same time of education, efforts to promote integrative approaches to psychosis should be made at the level of 
mental health care policies, academic medical curriculum and mental health staff training.  
 
Strengths and limitations of the study 
This is the first study carried out in Italy that has specifically investigated causal beliefs of schizophrenia 
among non-psychiatric doctors and whether differential belief in biogenetic vs. psychosocial causes would 
influence medical sample of non-psychiatric doctors. Strengths include the face-to-face collection of the data 
and the high participation rate (87%). The use of a validated self-reported instruments is a further strength, 
which may facilitate the replication of the survey in other healthcare contexts.  
This study also has a number of limitations, indicating the need for some caution in the interpretation of 
its results. In particular, the rather high mean age of the sample (58 years) might make the results 
unrepresentative of younger, more junior, doctors. However, the finding that age was unrelated to causal 
beliefs (type of causes: F=0.18, df 2, 283, p=0.83; most important cause: F=0.73, df 1, 243; p=0.39) or to 
opinions about treatments (usefulness of drugs: Pearson’s r = 0.09, p< 0.14; usefulness of psychological 
therapies: r = -0.06, p<0.27; needs of life-term pharmacological therapies: r=0.02, p=0.69) and recovery 
(r=0.01, p=0.87) suggests that this may not be a serious limitation. Similarly, the limitation that 77% of the 
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sample was male - a condition which would not be a fair gender representation - is somewhat mitigated by the 
finding that gender was not significantly related to causal beliefs (type of causes: χ2=2.8, df 2, p=0.25; most 
important cause: χ2=1.18, df 1, p=0.28) or to opinions about treatments and possibility of recovery (MANOVA 
Wilks’λ=0.02, F (4,300)=1.28, p=0.28).  
The fact that the study was conducted with doctors working in primary care unit of only one local health 
authority located in Southern Italy - a geographical area where mental and non-mental healthcare resources 
are poorer than in Central and Northern Italy (Magliano et al., 2002; Ministero della Salute - Agenzia Nazionale 
per i Servizi Sanitari Regionali, 2017) -   is a limitation which might have influenced respondents’ beliefs about 
treatments and prognosis. However, the lack of other Italian studies on non-mental health professionals’ beliefs 
about people with schizophrenia and the care of this disorder means we do not know whether our findings are 
generalizable to other areas of Italy (or beyond). We are planning to extend the study to other geographical 
areas of Italy – possibly using an online data collection procedure.  
It must also be noted that the data collected are from a cross-sectional study. Therefore, we cannot 
be certain that the relationships we found between causal beliefs and other variables are necessarily causal, 
or, if causal, that they are in the direction we hypothesised. It is conceivable, for example, that belief in the 
efficacy of medications has led to, or strengthened, bio-genetic causal beliefs. Alternatively, such beliefs might 
be reciprocally reinforcing. The revised OQ has been developed and validated only in Italian. The process of 
translation and adaptation of the tool to other health and cultural contexts might have delayed the replication 
of the survey in other countries.   
The survey investigated only beliefs, while no data has been collected on whether respondents’ beliefs 
about causes and treatments of schizophrenia influence clinical practices (for instance, the prescription of 
drugs for physical health problems requiring discontinuation of psychiatric drugs). Finally, although 82.2% of 
participants reporting that they have treated at least one client with this disorder, no information was collected 
on the intensity and the quality of such professional relationships. Therefore, it is conceivable that respondents’ 
opinions were somehow influenced by degree of experience. Some of these limitations will be addressed in 
further studies.  
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PRACTITIONER POINTS 
• Viewing schizophrenia as mainly due to a biological cause is associated with greater confidence in the 
usefulness of drugs, higher belief in the need for life-term pharmacological treatments, and greater 
prognostic pessimism 
• Belief in a biologically-oriented model of schizophrenia may lead doctors to underestimate the value 
of psychologists 
• Prognostic pessimism amongst doctors may negatively influence clinical decisions, the information 
doctors provide to their clients, and clients’ own beliefs about their chances of recovery 
• Belief in the need for life-long pharmacological treatments in schizophrenia may lead doctors to resist 
drug withdrawal in case of severe side effects 
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APPENDIX A 
Some people sometimes seem unable to distinguish between things that really happen and are 
experienced by other people, and things that happen only in their mind. Sometimes, these people believe or 
say things that seem bizarre or absurd to other people, or hear voices, smell things, or see images that other 
people do not. Sometimes, these people may have difficulty expressing their feelings or behaving appropriately 
(for instance, they may cry in response to a positive event, or may appear happy following an unpleasant one), 
or they may remain shut up in their house for a long time, or talk very little or not at all. They behave as if they 
lived in a world of their own, apparently without interest in anything or anybody. Sometimes they may have 
muddled thoughts, may invent odd or incomprehensible words, may lose the thread of the speech, or they may 
jump from one issue to another with no apparent reason. 
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TABLE 1. DOCTORS’ SOCIO-DEMOGRAPHIC VARIABLES AND PROFESSIONAL 
BACKGROUND CHARACTERISTICS (N=305). 
 
Variables   
Sex, N (%) Male 235 (77.0) 
 Female   70 (23.0) 
Age (mean ± sd)  57.8 ± 5.57 
Years from the achievement  1-10 years         0 
of MD Degree, N (%) 11-20    10  (3.3) 
 >20  293 (96.7) 
Type of doctors, N (%) GPs 192 (63.0) 
 Specialists 113 (37.0) 
Doctors with at least one client  Yes 245 (82.2) 
with schizophrenia, N (%) No   53 (17.8) 
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TABLE 2.  DOCTORS’ BELIEFS ABOUT CAUSAL FACTORS OF SCHIZOPHRENIA (N=305). 
  
Causes N % 
Heredity 199 65.2 
Use of street drugs 165 54.1 
Psychological violence 140 45.9 
Traumatic events 136 44.6 
Use of alcohol 129 42.3 
Stress 127 41.6 
Chemical imbalance 113 37.0 
Family conflicts 104 34.1 
Bereavements 93 30.5 
Sexual abuses 87 28.5 
Physical violence 82 26.9 
Poor parenthood/abandonment 77 25.2 
Work difficulties 76 24.9 
Disillusionment in love 70 23.0 
Physical illness 60 19.7 
Illness in pregnancy 40 13.1 
Others*   3   1.0 
 
Type of endorsed causes 
  
Only biogenetic  50  16.4 
Biological and psychosocial 229 75.1 
Only psychosocial  26   8.5 
 
* endogenous causes, a combination of more causes, geriatric causes 
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TABLE 3.  DOCTORS’ BELIEFS ABOUT THE MOST IMPORTANT CAUSE OF SCHIZOPHRENIA (N=264). 
 
Causes N % 
Biogenetic 142/264 53.8 
Heredity  86/142 60.6 
Chemical imbalance  21/142 14.8 
Use of street drugs and/or alcohol  19/142 13.4 
Physical illness  10/142   7.0 
Heredity associated with use of drugs/alcohol    3/142   2.1 
Illness in pregnancy    2/142   1.4 
Cerebrovascular disease    1/142   0.7 
Psychosocial  122/264 46.2 
Stress  23/122 18.8 
Family conflicts  22/122 18.0 
Traumatic events  22/122 18.0 
Psychological violence  19/122 15.6 
Work difficulties    8/122   6.5 
Poor parenthood/abandonment    7/122   5.7 
Bereavements    4/122   3.3 
Sexual abuses    3/122   2.4 
Physical violence    1/122   0.8 
Disillusionment in love    1/122   0.8 
Frequenting bad companies    1/122   0.8 
Difficulty in relating to reality    1/122   0.8 
Violence in general    1/122   0.8 
Physical and psychological violence    3/122   2.4 
Traumatic events and family conflicts    1/122   0.8 
Physical and psychological violence and sexual abuse    1/122   0.8 
Physical and psychological violence and abandonment    1/122   0.8 
Traumatic events and psychological violence    1/122   0.8 
Bereavement and abandonment    1/122   0.8 
Family conflicts and work difficulties    1/122   0.8 
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TABLE 4. DOCTORS’ VIEWS OF TREATMENTS AND PROGNOSIS OF SCHIZOPHRENIA (N=305). 
 Doctors’  answers 
OQ’s items 
“Not true” “Partially 
true” 
“Completely 
true” 
 N % N % N % 
† can recover 28  9.8 174 61.1 83 29.1 
Drugs are useful for †  5  1.7 141 46.5 157 51.8 
Psychological interventions are useful  for †  4  1.3 127 42.8 166 55.9 
† must take drugs all their life 72 25.2 117 40.9 97 33.9 
If stop taking drugs, † become dangerous 101 36.1 137 48.9 42 15.0 
If stop taking drugs, † become unwell again 36 12.5 163 56.8 88 30.7 
 
† people with a disorder like that reported in the description 
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TABLE 5. DOCTORS’ VIEWS OF TREATMENTS AND PROGNOSIS IN SCHIZOPHRENIA: DIFFERENCES RELATED TO 
CAUSES ENDORSED AS THE MOST IMPORTANT ONES (BIOGENETIC VS. PSYCHOSOCIAL). 
 Most important causes  
 Biogenetic Psychosocial MANOVA 
OQ factors Mean SD Mean SD F (1,265), p 
Possibility to recover 2.09 0.56 2.35 0.55 13.96** 
Usefulness of drugs  2.62 0.51 2.38 0.54 13.04** 
Usefulness of psychological  therapies 2.53 0.53 2.59 0.49 0.80;.37 
Needs of life-term pharmacological  treatments 2.11 0.53 1.89 0.55 12.04* 
 
Multivariate Analysis of Variance (MANOVA): dependent variables = mean scores of 1-4 QO section d factors; independent 
variables = type of most important cause (biogenetic and psychosocial) groups; Wilks’λ = 0.89, F (4,259) = 7.80, p< 0.0001; 
*p<0.001; **p<0.0001. 
